Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - PALISADE BIO, INC. | exh_311.htm |
| EX-23.01 - EXHIBIT 23.01 - PALISADE BIO, INC. | exh_2301.htm |
| EX-14.01 - EXHIBIT 14.01 - PALISADE BIO, INC. | exh_1401.htm |
| 10-K - FORM 10-K - PALISADE BIO, INC. | f10k_031518p.htm |
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Richard Daly, certify, as of the dates hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Neuralstem, Inc. on Form 10-K for the fiscal year ended December 31, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-K fairly presents in all material respects the financial condition and results of operations of Neuralstem, Inc. at the dates and for the periods indicated.
Date: April 2, 2018
| By: | /s/ Richard Daly | |
| Richard Daly | ||
| Chief Executive Officer and Chief Financial Officer (Principal Executive and Financial Officer) |
A signed original of this written statement required by Section 906 has been provided to Neuralstem, Inc. and will be retained by Neuralstem, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.